Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zanamivir for Endothelial Dysfunction in Type 2 Diabetes
NCT04867707Phase 2Completed
- Sponsor
- University of Missouri
- Start
- Jul 2021
- Primary completion
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of zanamivir in type 2 diabetes mellitus (T2DM), sponsored by University of Missouri. Started Jul 2021; status: completed.
02
Drugs
zanamivir
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT04867707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04867707.